The U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 protein, which...

Global drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...

Heads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...

Amgen will invest $200 million in its new technology centre in Hyderabad, India, this year, with plans for further investments. The centre,...

Amgen leases 500,000 sq ft in Hyderabad to establish its first global capability centre, enhancing its office space in the city. The new ce...

US biotech giant Amgen announced plans to open a new technology and innovation site in Hyderabad, India. The site will be located in HITEC ...

A notable book that emphasized the importance of corporate culture by looking at successful companies (stock price performance as a guide) ...

A formal stipulation of dismissal has been filed with the court and is awaiting signature by the presiding Judge, the filing added.

Biocon and Mylan have been working for a decade on a biosimilar version of the drug, originally sold by Amgen under brand name Enbrel.

They have established players in drug discovery, development and manufacturing, especially in the biologics areas, the large molecule area.

Under the terms, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said...

Shares of Dr Reddy's Laboratories rose almost 2% after the company said it has inked a pact with US-based biotechnology firm Amgen to marke...

Dr Reddy's Laboratories today said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs.

Amgen, the world's largest biotechnology company, agreed to buy Micromet in a $1.16 billion deal to gain an experimental leukemia drug.

Cipla, the Indian drugmaker that built a $1-billion business making generic HIV treatments, aims to sell copies of Roche Holding's and Amge...

India's largest drug maker, Dr Reddy’s Laboratories, is planning to introduce its first biosimilar drug by 2010 in Europe, a senior company...

A new chapter is being added to the Indian pharma story. Leading global pharma and biotechnology firms, such as Schering-Plough, Bristol-My...